Screener
Biogen BIIB Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Biogen in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Biogen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 6:36 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000875045-26-000075
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue from anti-CD20 therapeutic programs | 513.5 | 467.3 | 932.6 | 845.5 |
| Alzheimer's collaboration revenue | 63.7 | 54.9 | 123.2 | 87.9 |
| Contract manufacturing, royalty and other revenue | 242.4 | 244.6 | 489.3 | 537.9 |
| Total revenue | 2,736.0 | 2,645.5 | 5,213.8 | 5,076.5 |
| Cost and expense: | ||||
| Cost of sales, excluding amortization and impairment of acquired intangible assets | 776.9 | 605.0 | 1,437.9 | 1,234.3 |
| Research and development | 529.6 | 399.0 | 1,068.6 | 833.1 |
| Acquired in-process research and development, upfront and milestone expense | 164.0 | 46.6 | 198.0 | 247.3 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Biogen's total revenue?
- Biogen (BIIB) reported total revenue of $2.74B in Q2 2026.
- How has Biogen's total revenue changed year-over-year?
- Biogen's total revenue increased by 3.4% year-over-year, from $2.65B to $2.74B.
- What is the long-term trend for Biogen's total revenue?
- Over 4 years (2021 to 2025), Biogen's total revenue has grown at a -2.6% compound annual growth rate (CAGR), from $10.98B to $9.89B.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Biogen's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude